Seven Bridge Financial Group, LLC Corcept Therapeutics Inc Transaction History

Seven Bridge Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $29,758 - $38,297	-1,945 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$14.59 - $25.5 $802 - $1,402	-55 Reduced 2.75%	1,945 $32,000
Q4 2017 Feb 20, 2018	SELL	$15.77 - $20.72 $27,597 - $36,260	-1,750 Reduced 46.67%	2,000 $36,000
Q3 2017 Nov 13, 2017	BUY	$12.3 - $19.3 $7,995 - $12,545	650 Added 20.97%	3,750 $72,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,100	3,100 $37,000

311

88.3M

1.07M

973K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $4.71B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.